Fareed Khawaja

Fareed Khawaja is a Senior Professor at The University of Texas MD Anderson Cancer Center, specializing in infectious diseases, medical virology, and immunology, with a particular focus on transplant infectious diseases in hematology and bone marrow transplantation. His research centers on viral reactivation and infectious complications following allogeneic hematopoietic cell transplantation and CD19 chimeric antigen receptor T-cell therapy. His recent work (2026) examines cytomegalovirus end-organ disease in the era of letermovir prophylaxis, human herpesvirus 6 reactivation after haploidentical transplantation, and humoral responses to pneumococcal conjugate vaccines in lymphoma survivors. He has published extensively in venues such as *Transplantation and Cellular Therapy* and *Open Forum Infectious Diseases*, contributing to clinical guidelines for managing infections in immunocompromised patients.